Biomarkers in Heart Failure

Biomarkers are crucial for diagnosing, monitoring, and predicting outcomes in heart failure. They complement imaging and clinical evaluation.

Key Highlights:

  • Natriuretic peptides: BNP and NT-proBNP indicate heart failure severity.
  • Cardiac troponins: Detect ongoing myocardial injury.
  • Inflammatory markers: CRP and interleukins reflect systemic inflammation.
  • Renal biomarkers: Help detect cardiorenal syndrome.
  • Therapeutic monitoring: Biomarkers guide medication titration and therapy response.

Using biomarkers improves early detection, guides personalized therapy, and reduces complications in heart failure management.

    Related Conference of Biomarkers in Heart Failure

    October 06-07, 2025

    6th International Conference on Physics

    Paris, France
    December 01-02, 2025

    9th International Meeting on Fluid Dynamics & Fluid Mechanics

    Vancouver, Canada
    December 15-16, 2025

    13th World Congress on Physical and Theoretical Chemistry

    Amsterdam, Netherlands
    February 09-10, 2026

    9th World Congress On Cardiology and Heart Failure

    London, UK
    February 19-20, 2026

    4th World Congress on Quantum Physics

    Paris, France

    Biomarkers in Heart Failure Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in